Selected article for: "available data and increase risk"
Author: Głuchowska, Kinga; Dzieciątkowski, Tomasz; Sędzikowska, Aleksandra; Zawistowska-Deniziak, Anna; Młocicki, Daniel
Title: The New Status of Parasitic Diseases in the COVID-19 Pandemic—Risk Factors or Protective Agents?
  • Cord-id: 79vrdh62
  • Document date: 2021_6_7
    • ID: 79vrdh62
    Snippet: It is possible that parasites may influence the course of COVID-19 infection, as either risk factors or protective agents; as such, the current coronavirus pandemic may affect the diagnosis and prevention of parasitic disease, and its elimination programs. The present review highlights the similarity between the symptoms of human parasitoses and those of COVID-19 and discuss their mutual influence. The study evaluated selected human parasitoses with similar symptoms to COVID-19 and examined thei
    Document: It is possible that parasites may influence the course of COVID-19 infection, as either risk factors or protective agents; as such, the current coronavirus pandemic may affect the diagnosis and prevention of parasitic disease, and its elimination programs. The present review highlights the similarity between the symptoms of human parasitoses and those of COVID-19 and discuss their mutual influence. The study evaluated selected human parasitoses with similar symptoms to COVID-19 and examined their potential influence on SARS-CoV-2 virus invasion. The available data suggest that at least several human parasitoses could result in misdiagnosis of COVID-19. Some disorders, such as malaria, schistosomiasis and soil-transmitted helminths, can increase the risk of severe infection with COVID-19. It is also suggested that recovery from parasitic disease can enhance the immune system and protect from COVID-19 infection. In addition, the COVID-19 pandemic has affected parasitic disease elimination programs in endemic regions and influenced the number of diagnoses of human parasitoses.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and abnormal coagulation: 1
    • abdominal pain and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
    • abdominal pain and liver spleen: 1, 2, 3, 4
    • abdominal pain and local hospital: 1
    • abdominal pain and local infiltration: 1, 2
    • abdominal pain and low incidence: 1, 2, 3
    • abdominal pain and low mortality: 1, 2
    • abdominal pain and low number: 1
    • abdominal pain and lung biopsy: 1
    • abdominal pain and lung cancer: 1
    • abdominal pain and lung heart: 1, 2
    • abdominal pain and lung infection: 1, 2, 3, 4
    • abdominal pain and lung inflammation: 1
    • abdominal pain and lung parenchyma: 1
    • abdominal pain and lymph node: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain diarrhea and abnormal coagulation: 1
    • abdominal pain diarrhea and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain diarrhea and low mortality: 1
    • abdominal pain diarrhea and lung cancer: 1